Jessica Hopfield's Net Worth

$2.69 Million

Estimate Recalculated May 14, 2024 03:20PM EST

Who is Jessica Hopfield?

Jessica Hopfield has an estimated net worth of $2.69 Million. This is based on reported shares across multiple companies, which include INSULET CORP, Bruker Cellular Analysis, Inc., Editas Medicine, Inc., Radius Health, Inc., and MARAVAI LIFESCIENCES HOLDINGS, INC..

SEC CIK

Jessica Hopfield's CIK is 0001648715

Past Insider Trading and Trends

2021 was Jessica Hopfield's most active year for acquiring shares with 7 total transactions. Jessica Hopfield's most active month to acquire stocks was the month of April. 2023 was Jessica Hopfield's most active year for disposing of shares, totalling 2 transactions. Jessica Hopfield's most active month to dispose stocks was the month of September. 2020 saw Jessica Hopfield paying a total of $1,350,000.00 for 89,919 shares, this is the most they've acquired in one year. In 2023 Jessica Hopfield cashed out on 179,237 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INSULET CORP (PODD) Snapshot price: $199.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.41%
843
—
—
25.54K
May 23
Form 4
+4.26%
1.01K
—
—
24.69K
May 24
Form 4
+3.53%
808
—
—
23.68K
May 27
Form 4
+4.71%
1.03K
—
—
22.88K
May 28
Form 4
+8.58%
1.73K
—
—
21.85K
May 30
Form 4
+12.18%
2.19K
—
—
20.12K
May 16
Form 4
+17.79%
2.71K
—
—
17.94K
May 17
Form 4
+20.40%
2.58K
$38.68
$99,782.53
15.23K
May 11
Form 4
+43.11%
3.81K
—
—
12.65K
May 11
Form 4
+57.60%
3.23K
$30.91
$99,839.30
8.84K
Mar 2
Form 4
∞
5.61K
—
—
5.61K
Jul 27
Form 3
—
0
—
—
0
No matching records found

Bruker Cellular Analysis, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-179.24K
—
—
0
Oct 2
Form 4
+64.08%
70K
—
—
179.24K
May 25
Form 4
+21.82%
19.57K
—
—
109.24K
May 26
Form 4
+827.13%
80K
$6.28
$502,400.00
89.67K
Mar 10
Form 4/A
—
0
—
—
0
Dec 15
Form 4
∞
9.67K
—
—
9.67K
Dec 15
Form 3
—
0
—
—
0
No matching records found

Editas Medicine, Inc. (EDIT) Snapshot price: $7.15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+198.24%
45K
$5.64
$253,867.50
67.7K
May 13
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 3
Form 4
+34.32%
5.8K
$45.51
$263,969.60
22.7K
Mar 3
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 12
Form 4
+152.24%
10.2K
$23.94
$244,188.00
16.9K
Mar 5
Form 4
∞
6.7K
$37.28
$249,780.02
6.7K
May 17
Form 4
—
0
—
—
0
Feb 14
Form 3
—
0
—
—
0
No matching records found

Radius Health, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+42.97%
5.5K
—
—
18.3K
Feb 20
Form 4
∞
12.8K
$19.23
$246,190.08
12.8K
Mar 5
Form 4
—
0
—
—
0
Jan 24
Form 3
—
0
—
—
0
No matching records found

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) Snapshot price: $5.485

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+36.30%
24K
—
—
90.12K
Jul 17
Form 4
+6.91%
4.27K
—
—
66.12K
Nov 19
Form 4
+421.87%
50K
$27.00
$1,350,000.00
61.85K
Nov 24
Form 4
∞
11.85K
—
—
11.85K
Nov 19
Form 3
—
0
—
—
0
No matching records found